TATA Health International Holdings (SEHK:1255) Income Statement Analysis 2012-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2022	2024	LTM
Total Revenue	HK$144.606M	HK$124.455M	HK$42.118M
Cost of Sales	HK$30.662M	HK$39.507M	HK$7.285M
Gross Profit	HK$113.944M	HK$84.948M	HK$34.833M
Research And Development Expenses	-	-	-
Selling, General And Administrative Expenses	HK$144.02M	HK$139.809M	HK$56.017M
Other Expenses	-	-	-
Operating Profit	HK$-30.062M	HK$-54.861M	HK$-21.184M
Net Interest Income	HK$-1.049M	HK$-4.248M	HK$-1.332M
Other Non-operating Income	HK$35.215M	HK$-8.922M	HK$43.112M
Total Non-operating Income	HK$34.166M	HK$-13.17M	HK$41.78M
EBT	HK$4.104M	HK$-68.031M	HK$20.596M
Income Tax Expense	HK$898K	HK$307K	-
Net Income	HK$9.613M	HK$-68.338M	HK$20.596M

Earnings Per Share (Basic)	HK$0.04	HK$-0.28	HK$0.085
Earnings Per Share (Diluted)	HK$0.04	HK$-0.28	HK$0.085
Weighted-Average Shares Outstanding (Basic)	HK$242.845M	HK$242.846M	HK$242.846M
Weighted-Average Shares Outstanding (Diluted)	HK$242.845M	HK$242.845M	HK$242.845M

EBITDA	HK$18.615M	HK$-39.322M	HK$-15.96M
Depreciation And Amortization	HK$12.017M	HK$15.539M	HK$5.224M
EBIT	HK$6.598M	HK$-54.861M	HK$-21.184M

TATA Health International Holdings Income Statement

Revenue And Expenses Breakdown